Shandong, China

Wenyi Guo

This inventor holds 1 USPTO granted patent. Top assignees: Bloomage Biotech (Tianjin) Co., Ltd., Bloomage Biotechnology Corporation Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenyi Guo. Retrieved from https://idiyas.com/inventor/wenyi-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wenyi Guo: Inventor in Biotechnology

Introduction

Wenyi Guo is an inventor associated with biotechnology research in Shandong, China. Her patent work concerns stabilizing ergothioneine using hyaluronic acid or its salts and/or trehalose.

Latest Patents

The available information lists one patent associated with Wenyi Guo: “Use of Hyaluronic Acid or Salt Thereof and/or Trehalose in Stabilizing Ergothioneine, and Ergothioneine Composition Containing Hyaluronic Acid or Salt Thereof and/or Trehalose.” The invention addresses an ergothioneine composition and methods for improving its stability. The record lists 1 patent.

Career Highlights

Guo is associated with Bloomage Biotechnology Corporation Limited and Bloomage Biotech (Tianjin) Co., Ltd. Her listed patent reflects work on ingredient stabilization and composition development in biotechnology.

Collaborations

The listed coworkers associated with Guo are Yujie Wei and Zhen Lu. Their names appear alongside the patent information provided.

Conclusion

Wenyi Guo’s listed invention focuses on stabilizing ergothioneine with hyaluronic acid or its salts and/or trehalose, reflecting her connection to biotechnology research and product development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…